Modern Fixed Combinations in the Correction of Arterial Hypertension and Dyslipidemia

Author:

Galeeva Z. M.1ORCID,Galyavich A. S.1ORCID,Baleeva L. V.1ORCID,Sabirzyanova A. A.1ORCID,Kuznetsov M. V.2ORCID

Affiliation:

1. Kazan State Medical University

2. Primary Healthcare Unit, Kazan (Volga Region) Federal University

Abstract

Based on a clinical case report, the article shows the individual selection of effective therapy for a patient with arterial hypertension and dyslipidemia. Taking into account the risk factors for cardiovascular diseases, Equamer® was selected as a fixed combination of amlodipine + lisinopril + rosuvastatin capsules 10 mg+20 mg+10 mg (Gedeon Richter Plc, Budapest, Hungary). In the patient with hypertension, ischemic heart disease was verified, and stenting of the anterior descending artery was performed. According to the clinical guidelines, when arterial hypertension is associated with ischemic heart disease, the drug therapy of choice should be a combination of dihydropyridine slow calcium channel blockers with an angiotensin-converting enzyme inhibitor. The fixed triple combination of amlodipine, lisinopril, and rosuvastatin is one of the most appropriate in this clinical situation; this combination targets the two major risk factors for cardiovascular diseases, arterial hypertension and dyslipidemia.

Publisher

APO Society of Specialists in Heart Failure

Reference22 articles.

1. European Heart Network. Early detection of cardiovascular disease – an update from the European Heart Network – 2020. Av. at: https://ehnheart.org/wp-content/uploads/2023/08/EHN_CVD_Risk_Assessment_Programmes_Jan2021.pdf

2. Josipović J, Brčić K. Triple Combination, Two Diseases, and a Single Tablet. Cardiologia Croatica. 2023;18(5–6):188–92. DOI: 10.15836/ccar2023.188

3. World Health Organisation. Cardiovascular diseases (CVDs). [Internet] Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

4. Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, LuengoFernandez R et al. European cardiovascular disease statistics 2017 edition. European Heart Network, Brussels. Av at: http://www.ehnheart. org/images/CVD-statistics-report-August-2017.pdf

5. Coca A, Kreutz R, Manolis AJ, Mancia G. A practical approach to switch from a multiple pill therapeutic strategy to a polypill-based strategy for cardiovascular prevention in patients with hypertension. Journal of Hypertension. 2020;38(10):1890–8. DOI: 10.1097/HJH.0000000000002464

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3